ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
andante
|
71 |
33K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
71
|
33K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
andante
|
71 |
33K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
71
|
33K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
andante
|
71 |
33K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
71
|
33K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS PharmaQC Commercially Ready - Performance Finalised
|
|
andante
|
71 |
33K |
6 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
71
|
33K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Company Presentation
|
|
andante
|
3 |
1.4K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
3
|
1.4K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Presented at Australian Pharmaceutical Conference
|
|
andante
|
11 |
3.8K |
2 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
11
|
3.8K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Presented at Australian Pharmaceutical Conference
|
|
andante
|
11 |
3.8K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
11
|
3.8K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Presented at Australian Pharmaceutical Conference
|
|
andante
|
11 |
3.8K |
0 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
11
|
3.8K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: APAS Presented at Australian Pharmaceutical Conference
|
|
andante
|
11 |
3.8K |
10 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
11
|
3.8K
|
10
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Renounceable Rights Issue Results
|
|
andante
|
6 |
1.7K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
6
|
1.7K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
LBTR
|
|
andante
|
5 |
2.1K |
0 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5
|
2.1K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
LBTR
|
|
andante
|
5 |
2.1K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $4.5 million Entitlement Offer
|
|
andante
|
37 |
17K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
37
|
17K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $4.5 million Entitlement Offer
|
|
andante
|
37 |
17K |
2 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
37
|
17K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $4.5 million Entitlement Offer
|
|
andante
|
37 |
17K |
7 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
37
|
17K
|
7
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $4.5 million Entitlement Offer
|
|
andante
|
37 |
17K |
3 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
37
|
17K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Proposed issue of securities - LBT
|
|
andante
|
6 |
2.0K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
andante
|
16 |
6.8K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
16
|
6.8K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Proposed issue of securities - LBT
|
|
andante
|
20 |
8.6K |
2 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
20
|
8.6K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: LBT Strengthens APAS Pharma Development
|
|
andante
|
13 |
6.1K |
6 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
13
|
6.1K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
andante
|
12 |
5.0K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
12
|
5.0K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
5 months since good news
|
|
andante
|
151 |
53K |
3 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
151
|
53K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
5 months since good news
|
|
andante
|
151 |
53K |
6 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
151
|
53K
|
6
|
|
ASX - By Stock
|
LBT |
Re:
5 months since good news
|
|
andante
|
151 |
53K |
1 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
151
|
53K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Appendix 4C - quarterly
|
|
andante
|
40 |
15K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
40
|
15K
|
2
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Appendix 4C - quarterly
|
|
andante
|
40 |
15K |
1 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
40
|
15K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Appendix 4C - quarterly
|
|
andante
|
40 |
15K |
4 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
40
|
15K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Change of Director's Interest Notice
|
|
andante
|
7 |
3.2K |
0 |
24/12/20 |
24/12/20 |
ASX - By Stock
|
7
|
3.2K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Proposed issue of Securities - LBT
|
|
andante
|
4 |
1.5K |
0 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
LBT Biotech |
Re:
LBT Innovations (ASX:LBT) moves on European market
|
|
andante
|
5 |
5.5K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
5
|
5.5K
|
1
|
|
ASX - By Stock
|
LBT Biotech |
Re:
Video: APAS Independence installation at Halo, HSL, London.
|
|
andante
|
14 |
4.8K |
1 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
14
|
4.8K
|
1
|
|
ASX - By Stock
|
LBT Biotech |
Re:
Video: APAS Independence installation at Halo, HSL, London.
|
|
andante
|
14 |
4.8K |
0 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
14
|
4.8K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Chairman's Address to Shareholders
|
|
andante
|
1 |
750 |
2 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
1
|
750
|
2
|
|
ASX - By Stock
|
LBT |
Re:
$2 Club
|
|
andante
|
80 |
72K |
3 |
11/11/20 |
11/11/20 |
ASX - By Stock
|
80
|
72K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
andante
|
10 |
2.9K |
4 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
10
|
2.9K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Investor Webinar Presentation
|
|
andante
|
16 |
7.2K |
0 |
12/09/20 |
12/09/20 |
ASX - By Stock
|
16
|
7.2K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Share Purchase Plan
|
|
andante
|
31 |
9.3K |
0 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
31
|
9.3K
|
0
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Share Purchase Plan
|
|
andante
|
31 |
9.3K |
2 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
31
|
9.3K
|
2
|
|
ASX - By Stock
|
LBT Biotech |
Re:
Video: Investor Updates with Brent Barnes, LBT Innovations - APAS technology installation in a UK Lab
|
|
andante
|
17 |
6.2K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
17
|
6.2K
|
1
|
|
ASX - By Stock
|
LBT Biotech |
Re:
Video: Investor Updates with Brent Barnes, LBT Innovations - APAS technology installation in a UK Lab
|
|
andante
|
17 |
6.2K |
1 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
17
|
6.2K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
Ann: $8M PRIVATE PLACEMENT & LAUNCH OF SPP
|
|
andante
|
52 |
14K |
4 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
52
|
14K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Trading Halt
|
|
andante
|
47 |
14K |
4 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
47
|
14K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Employee Incentive Plan
|
|
andante
|
15 |
5.5K |
4 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
15
|
5.5K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Employee Incentive Plan
|
|
andante
|
15 |
5.5K |
4 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
15
|
5.5K
|
4
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Employee Incentive Plan
|
|
andante
|
15 |
5.5K |
3 |
06/06/20 |
06/06/20 |
ASX - By Stock
|
15
|
5.5K
|
3
|
|
ASX - By Stock
|
LBT |
Re:
Ann: Employee Incentive Plan
|
|
andante
|
15 |
5.5K |
5 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
15
|
5.5K
|
5
|
|
ASX - By Stock
|
LBT |
Re:
Operation Normal
|
|
andante
|
91 |
34K |
1 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
91
|
34K
|
1
|
|
ASX - By Stock
|
LBT |
Re:
APAS, it’s time has arrived and it’s never been more obvious
|
|
andante
|
10 |
5.0K |
3 |
14/04/20 |
14/04/20 |
ASX - By Stock
|
10
|
5.0K
|
3
|
|
ASX - By Stock
|
NAB |
Re:
Meltdown followed by Stampede ?
|
|
andante
|
214 |
95K |
5 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
214
|
95K
|
5
|
|
ASX - By Stock
|
NAB |
Re:
Ann: Issue of ordinary shares on conversion of NAB Capital Notes
|
|
andante
|
13 |
5.9K |
4 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
13
|
5.9K
|
4
|
|